TCL Archive In Brief: NCAB Objects To Low Priority For Several Cancer Control Grants, Asks For New Review June 22, 1979
TCL Archive Perjeta, Herceptin & Docetaxel Combination Extended Survival in HER2-Positive Disease December 28, 2012